Peytavin G - Search Results

1

Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.

Flandre P, Peytavin G, Meiffredy V, Saidi Y, Descamps D, Delagnes M, Brun-Vézinet F, Raffi F; Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team. Flandre P, et al. Among authors: peytavin g. Antivir Ther. 2002 Jun;7(2):113-21. Antivir Ther. 2002. PMID: 12212923 Clinical Trial.

2

[Experience with nevirapine taken once daily in 93 HIV-infected patients].

Allavena C, François C, Reliquet V, Perre P, Michau C, Peytavin G, Raffi F. Allavena C, et al. Among authors: peytavin g. Pathol Biol (Paris). 1999 May;47(5):563-5. Pathol Biol (Paris). 1999. PMID: 10418041 Clinical Trial. French.

3

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

Descamps D, Flandre P, Calvez V, Peytavin G, Meiffredy V, Collin G, Delaugerre C, Robert-Delmas S, Bazin B, Aboulker JP, Pialoux G, Raffi F, Brun-Vézinet F. Descamps D, et al. Among authors: peytavin g. JAMA. 2000 Jan 12;283(2):205-11. doi: 10.1001/jama.283.2.205. JAMA. 2000. PMID: 10634336 Clinical Trial.

4

[Management of therapeutic failure in HIV-infected patients].

Bossi P, Tubiana R, Calvez V, Peytavin G, Katlama C, Bricaire F. Bossi P, et al. Among authors: peytavin g. Presse Med. 2001 Apr 28;30(16):806-12. Presse Med. 2001. PMID: 11388154 Review. French.

5

Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response.

Duong M, Piroth L, Peytavin G, Forte F, Kohli E, Grappin M, Buisson M, Chavanet P, Portier H. Duong M, et al. Among authors: peytavin g. Clin Infect Dis. 2001 Aug 1;33(3):386-92. doi: 10.1086/321876. Epub 2001 Jun 21. Clin Infect Dis. 2001. PMID: 11438909

6

Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens.

Duong M, Piroth L, Grappin M, Forte F, Peytavin G, Buisson M, Chavanet P, Portier H. Duong M, et al. Among authors: peytavin g. HIV Clin Trials. 2001 Mar-Apr;2(2):128-35. doi: 10.1310/M3JR-G390-LXCM-F62G. HIV Clin Trials. 2001. PMID: 11590521 Clinical Trial.

7

Randomized salvage therapy with saquinavir-ritonavir versus saquinavir-nelfinavir for highly protease inhibitor-experienced HIV-infected patients.

Chavanet P, Piroth L, Grappin M, Buisson M, Gourdon F, Cabié A, Duong M, Brunel-Dalmas F, Peytavin G, Portier H. Chavanet P, et al. Among authors: peytavin g. HIV Clin Trials. 2001 Sep-Oct;2(5):408-12. doi: 10.1310/afde-2byx-mdgl-n6mp. HIV Clin Trials. 2001. PMID: 11673815 Clinical Trial.

8

Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavir.

Duval X, Lamotte C, Race E, Descamps D, Damond F, Clavel F, Leport C, Peytavin G, Vilde JL. Duval X, et al. Among authors: peytavin g. Antimicrob Agents Chemother. 2002 Feb;46(2):570-4. doi: 10.1128/AAC.46.2.570-574.2002. Antimicrob Agents Chemother. 2002. PMID: 11796381 Free PMC article.

9

Final analysis of the Trilège induction-maintenance trial: results at 18 months.

Flandre P, Raffi F, Descamps D, Calvez V, Peytavin G, Meiffredy V, Harel M, Hazebrouck S, Pialoux G, Aboulker JP, Brun Vezinet F. Flandre P, et al. Among authors: peytavin g. AIDS. 2002 Mar 8;16(4):561-8. doi: 10.1097/00002030-200203080-00007. AIDS. 2002. PMID: 11872999 Clinical Trial.

10

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial.

Meynard JL, Vray M, Morand-Joubert L, Race E, Descamps D, Peytavin G, Matheron S, Lamotte C, Guiramand S, Costagliola D, Brun-Vézinet F, Clavel F, Girard PM; Narval Trial Group. Meynard JL, et al. Among authors: peytavin g. AIDS. 2002 Mar 29;16(5):727-36. doi: 10.1097/00002030-200203290-00008. AIDS. 2002. PMID: 11964529 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters